Why some immune T cells may let lung cancer grow
Mechanisms of Immunosurveillance for Lung Cancer-the Role of CD8+ T Cells in Tumor Tolerance Induction
This work looks at whether a common immune cell (CD8+ T cell) can make the body tolerate lung cancer, aiming to help people with lung cancer get more effective immunotherapy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baltimore VA Medical Center NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11479568 on NIH RePORTER |
What this research studies
From a patient's point of view, researchers are studying why a type of immune cell called CD8+ T cell sometimes helps lung tumors grow instead of fighting them. They use mouse models of transplantable and chemically induced lung cancer to observe how these T cells change the immune response. The team will search for specific signals and molecules (including things like PD-L1 and inflammatory factors) and study how CD8+ T cells interact with natural killer cells. The goal is to produce lab data that can guide new immunotherapy ideas for Veterans and the general public.
Who could benefit from this research
Good fit: People with lung cancer (including Veterans) who may later qualify for immunotherapy trials based on these findings would be the most relevant patients.
Not a fit: Patients with cancers other than lung cancer or those seeking immediate clinical treatments are unlikely to benefit directly from this preclinical work.
Why it matters
Potential benefit: If successful, this work could point to new ways to improve immunotherapy so more people with lung cancer respond to treatment.
How similar studies have performed: Immune therapies aimed at CD8+ T cells have worked well in cancers like melanoma, but lung cancer has been less responsive, and this project explores a novel mechanism that may explain that difference.
Where this research is happening
Baltimore, United States
- Baltimore VA Medical Center — Baltimore, United States (Active)
Researchers
- Principal investigator: Krupnick, Alexander S. — Baltimore VA Medical Center
- Study coordinator: Krupnick, Alexander S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.